Levofloxacin-based triple therapy for Helicobacter pylori re-treatment

triple therapy  Interpretation Bismuth quadruple therapy is preferable to 14-day triple therapy in the first-line treatment in the face of rising prevalence of Conclusion In conclusion, current evidences suggest that Lactobacillus supplementation during treatment with standard triple therapy for H

The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of Second-line therapy depends on the first-line therapy and should not be the same treatment The options are: • Clarithromycin-based triple therapy for 14 days

In conclusion, the intravenous triple regimen, consisting of PPI, metronidazole, and levofloxacin, can be used in patients of H pylori- Interpretation Bismuth quadruple therapy is preferable to 14-day triple therapy in the first-line treatment in the face of rising prevalence of